Technologies related to Infectious diseases

Title
Anti-Arthropod Vector Vaccines, Methods of Selecting, and Uses Thereof
Ref: E-122-2001-0 | Updated: Sep 16, 2015
Single-Chain Antibody Fragment Protein Binding to HIV-1 Integrase
Ref: | Updated: Aug 1, 2001
Engineered Human Topoisomerase I
Ref: | Updated: Jul 1, 2001
Attenuated Host-Range Restricted Dengue Viruses Derived by Site-Directed Mutagenesis of the Conserved 3-Stem and Loop Structure in Genomic RNA for Use as Vaccines
Ref: E-067-1998-0 | Updated: Feb 28, 2011
A Plasmid for Expression of a More Soluble Form of HIV Integrase Protein in E. coli
Ref: | Updated: May 1, 2001
Modifications of HIV Env, Gag and Pol Enhance Immunogenicity for Genetic Immunization
Ref: E-275-2000-0 | Updated: Feb 1, 2001
Human T Cell Line Chronically Infected With HIV
Ref: E-143-1989-0 | Updated: Jan 1, 2001
Ribonuclease H1 - A Protein Expressed in Escherichia coli from a Cloned Human RNase H1 cDNA
Ref: | Updated: Jan 1, 2001
Ixodes scapularis Tissue Factor Pathway Inhibitor
Ref: E-208-2000-0 | Updated: Sep 16, 2015
Ixodes Salivary Anticomplement Protein
Ref: E-207-2000-0 | Updated: Sep 16, 2015
A Plasmid for Expression of a Soluble Form of HIV-1 Integrase Protein
Ref: | Updated: Oct 1, 2000
Method of Diagnosing Multidrug Resistant Tuberculosis
Ref: E-093-2000-0 | Updated: May 1, 2018
Conjugate Vaccine for Neisseria Meningitidis
Ref: E-078-1999-0 | Updated: Apr 1, 2000
Oligomeric HIV-1 Envelope Glycoproteins
Ref: E-200-1993-0 | Updated: Sep 16, 2015
Novel HIV Related Peptides
Ref: E-070-1999-2 | Updated: Sep 16, 2015
Methods For Inactivating Enveloped RNA Virus Particles And Compositions For Use Therewith
Ref: E-161-1997-0 | Updated: Jun 1, 1999
Probe To Identify Enteroinvasive E. coli And Shigella Species
Ref: E-034-1989-0 | Updated: Feb 1, 1999
Adeno-Associated Virus (AAV)-Based Eucaryotic Vectors
Ref: E-099-1990-0 | Updated: Jan 1, 1999
Lipopolysaccharide Carriers For Use In Vaccines
Ref: E-086-1991-0 | Updated: Jul 1, 1998
Nucleotide, Deduced Amino Acid Sequence, Isolation And Purification Of Heat-Shock Chlamydial Proteins
Ref: E-196-1989-0 | Updated: Feb 28, 2011
Nucleotide and Amino Acid Sequences of the Four Variable Domains of the Major Outer Membrane Proteins of Chlamydia trachomatis
Ref: E-003-1989-0 | Updated: May 6, 2016
Methods For Treating Parasitic Infection Using Thiopeptides
Ref: E-202-1997-0 | Updated: May 1, 1998
Phage Display Of Intact Domains At High Copy Number
Ref: E-061-1997-0 | Updated: Apr 1, 1998
STRL33, A Human Fusion Accessory Factor Associated With HIV Infection
Ref: E-087-1997-0 | Updated: Mar 1, 1998
Functional Promoter For CCR5
Ref: E-222-1997-0 | Updated: May 17, 2016
Antigenic Protein Of Borrelia Burgdorferi
Ref: E-056-1990-1 | Updated: Oct 1, 1997
Versatile Reagent For Detecting Murine Leukemia Viruses
Ref: E-059-1990-0 | Updated: Oct 1, 1997
Parvovirus B19 Receptor And Parvovirus B19 Detection
Ref: E-019-1993-0 | Updated: May 1, 1997
Monoclonal and Polyclonal Antibodies to 14-3-3 Proteins
Ref: | Updated: Feb 1, 1997
Production Of Infectious Respiratory Syncytial Virus From Cloned Nucleotide Sequences
Ref: | Updated: Nov 1, 1996
Cells Expressing Both Human CD4 And A Human Fusion Accessory Factor Associated With HIV Infection
Ref: E-017-1996-1 | Updated: Nov 1, 1996
Transmission-Blocking Vaccine Against Malaria (1)
Ref: E-035-1991-0 | Updated: Feb 28, 2011
Method For Immune Capture And Primary Isolation Of Borrelia Burgdorferi
Ref: E-032-1990-1 | Updated: Feb 1, 1994
Specific And Sensitive Diagnostic Test For Lyme Disease
Ref: E-226-1989-0 | Updated: Feb 1, 1994
Plasmodium vivax and Plasmodium knowlesi Duffy Receptor
Ref: E-090-1990-0 | Updated: Feb 28, 2011

Pages

Subscribe to Technologies related to Infectious diseases